CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Down 87.6% in December

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 19,100 shares, a decrease of 87.6% from the November 30th total of 154,200 shares. Based on an average daily volume of 232,200 shares, the short-interest ratio is presently 0.1 days.

CNBX Pharmaceuticals Trading Up 7.8 %

OTCMKTS CNBX traded up $0.00 during trading hours on Friday, hitting $0.01. The company’s stock had a trading volume of 10,094 shares, compared to its average volume of 180,918. CNBX Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.02. The stock has a fifty day moving average of $0.01 and a 200 day moving average of $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.